Stockscreener 앱 받기
4.59
22.40%
0.84
시간 외 거래:
5.04
0.45
+9.80%
전일 마감가:
$3.75
열려 있는:
$3.79
하루 거래량:
69,843
Relative Volume:
2.21
시가총액:
$47.09M
수익:
$79.32M
순이익/손실:
$-100.37M
주가수익비율:
-4.2929
EPS:
-1.0692
순현금흐름:
$-44.34M
1주 성능:
+22.73%
1개월 성능:
+50.74%
6개월 성능:
-44.70%
1년 성능:
-49.00%
1일 변동 폭
$3.79
$4.7299
1주일 범위
$3.42
$4.7299
52주 변동 폭
$2.62
$9.987
Burning Rock Biotech Ltd Adr Stock (BNR) Company Profile
BNR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| BNR | 4.59 | 47.09M | 79.32M | -100.37M | -44.34M | -1.0692 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Burning Rock Biotech Ltd Adr Stock (BNR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2020-07-07 | 개시 | Cowen | Outperform |
Burning Rock Biotech Ltd Adr 주식(BNR)의 최신 뉴스
NMPA Grants Marketing Approval to the First Co-Developed NGS-Based Companion Diagnostic for Lung Cancer in China - GlobeNewswire Inc.
Burning Rock Biotech CFO Leo Li resigns - Investing.com
Burning Rock Biotech Limited Announces the Resignation of Leo Li as Chief Financial Officer - Marketscreener.com
Brazil Multi Cancer Early Detection Market Size & Outlook, 2030 - Grand View Research
Burning Rock Biotech Limited Sponsored ADR (BNR) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo New Zealand News
LiveRamp (RAMP) Tops Q2 Earnings and Revenue Estimates - Yahoo New Zealand News
Burning Rock Biotech Limited Sponsored ADR (BNR) Reports Q2 Loss, Tops Revenue Estimates - Yahoo New Zealand News
Outbrain Inc. (OB) Reports Q4 Loss, Tops Revenue Estimates - Yahoo New Zealand News
Rackspace (RXT) Q2 Earnings Surpass Estimates - Yahoo Singapore News
Burning Rock (BNR) in Focus: Stock Moves 5.4% Higher - Yahoo Movies UK
Earnings call: Burning Rock returns to profitability in Q1 2024 By Investing.com - Investing.com Canada
Earnings call: Burning Rock returns to profitability in Q1 2024 - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.88% - Investing.com India
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024 - Investing.com India
New Strong Sell Stocks for November 6th - Yahoo Movies Canada
Why Shares of Alibaba, JD.com, and Burning Rock Biotech Are Rising Today - The Globe and Mail
FDA Grants Breakthrough Device Designation to A Multi-Cancer Detecting Blood Test - Cancer Network
What should you do if you own US-listed Chinese stocks ordered by SEC to delist? - Dr Wealth
HFCAA News: 128 Chinese Stocks the SEC Could Delist - InvestorPlace
Making it harder to "buy" China, Inc. - US-China Institute
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Markets Insider
BioLine Rx (NASDAQ:BLRX) Stock Quotes, Forecast and News Summary - Benzinga
Burning Rock Biotech (BNR) Stock Price, News & Analysis - MarketBeat
The Daily Biotech Pulse: Regulatory Setback For Fennec Pharma, Ligand To Buy Pfenex, Inovio Says Phase 2/ - Benzinga
Citi Appointed Depositary Bank for Burning Rock Biotech Limited’s Sponsored ADR Program - Business Wire
The Daily Biotech Pulse: GlaxoSmithKline, IDEAYA Strike Oncology Partnership, Decision Day For Merck, Adv - Benzinga
Burning Rock Biotech Ltd Adr (BNR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.04%
3.19%
자본화:
|
볼륨(24시간):